ArticleACS synthetic biology2025
Engineering Cell Fate with Adaptive Feedback Control.
Article in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Engineering cell fate is fundamental to optimizing therapies based on stem cells, which are aimed at replacing cells in patients suffering from trauma or disease. By timely administering molecular regulators (e.g., transcription factors, RNAs, or small molecules) in a process that mimics in vivo embryonic development, stem cell differentiation can be guided toward a specific cell fate. However, scaling up these therapies is extremely challenging because such differentiation strategies often result in mixed cellular populations. While synthetic biology approaches have been proposed to increase the yield of desired cell types, designing gene circuits that effectively redirect cell fate decisions requires mechanistic insight into the dynamics of the endogenous regulatory networks that govern this type of decision-making. In this work, we present a biomolecular adaptive controller designed to favor a specific cell fate. The controller, whose topology is akin to that of an Incoherent Feedforward Loop (IFFL), requires minimal knowledge of the endogenous network as it exhibits adaptive, non-reference-based behavior. The synthetic circuit operates through a sequestration mechanism and a delay introduced by an intermediate species, producing an output that asymptotically approximates a discrete temporal derivative of its input if the sequestration rate is sufficiently fast. Allowing the controller to actuate over a target species involved in the decision-making process creates a tunable synthetic bias that favors the production of the desired species with minimal alteration to the overall equilibrium landscape of the endogenous network. Through theoretical and computational analysis, we provide design guidelines for the controller's optimal operation, evaluate its performance under parametric perturbations, and extend its applicability to various examples of common multistable systems in biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.